{"id":"W2048514971","doi":"10.1097/qad.0b013e3283612419","title":"Dolutegravir in antiretroviral-naive adults with HIV-1","year":2013,"lang":"en","type":"article","venue":"AIDS","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":163,"is_retracted":false,"has_abstract":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Tolerability; Dolutegravir; Emtricitabine; Efavirenz; Medicine; Abacavir; Regimen; Adverse effect; Lamivudine; Internal medicine; Clinical endpoint; Viral load; Integrase inhibitor; Gastroenterology; Human immunodeficiency virus (HIV); Pharmacology; Randomized controlled trial; Virology; Antiretroviral therapy; Virus; Hepatitis B virus","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00004853325,0.000147474,0.0002312625,0.0001436803,0.00002751818,0.00001483723,0.00005233267,0.00005275346,0.000400169],"category_scores_gemma":[0.00001390241,0.00009607209,0.00003672907,0.000271362,0.00003398609,0.0001218163,0.00002047509,0.0001160339,0.001519049],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007535092,"about_ca_system_score_gemma":0.0000644395,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001825045,"about_ca_topic_score_gemma":0.00001309405,"domain_scores_codex":[0.9991629,0.00001701107,0.0001575353,0.0002218946,0.0001865517,0.0002541181],"domain_scores_gemma":[0.9995937,0.000023781,0.00003112101,0.0001984823,0.00004886062,0.0001040613],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001403229,0.0001705057,0.9819693,0.00002643418,0.00005635606,0.0001374864,0.0008341946,4.031723e-7,0.0002272975,0.000107099,0.005033618,0.01129701],"study_design_scores_gemma":[0.007632112,0.0009776577,0.9805702,0.0004984346,0.00007597561,0.00005308696,0.001016126,0.00009568251,0.003089067,0.0001175236,0.005584493,0.0002896575],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9860494,0.00009784796,0.00003021817,0.001350878,0.00003738338,0.0004713426,0.000002161595,0.00005238887,0.01190841],"genre_scores_gemma":[0.9674854,0.00002794925,0.005190026,0.0002066499,0.00004277248,0.00008491493,0.00004694285,0.00001843683,0.02689692],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01856398,"threshold_uncertainty_score":0.9992584,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006139543352020244,"score_gpt":0.2205028907488554,"score_spread":0.2143633473968352,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}